Trial Site Detail

 

Drug:
KTN0158
Trial:
A Study to Evaluate the Safety and Pharmacokinetics of KTN0158 in Adult Patients With Advanced Solid Tumors
Conditions: Any type of Cancer
Trial Status:
Ongoing, but not recruiting

 

Dana Farber Cancer Institute

450 Brookline Ave     
Boston , MA 02215-5450
USA

 

Principal Investigator:
Andrew J.Wagner, MD, PhD
Contact:
Melissa Hohos, RN 617-582-7162 mhohos@partners.org Emily Leonard, RN 617-632-3989 ealeonard@partners.org
Activation Status of this Site:
Closed
Notes about this Site:
Dana Farber Cancer Institute Website:
http://www.dana-farber.org/Research/Clinical-Trials.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.